Animal models of human disease: Zebrafish swim into view

Nature Reviews Genetics

Volumn 8, Issue 5, 2007, Pages 353-367

  Lieschke, Graham J ^a   Currie, Peter D ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GS 3999; GS 4012; GS 4898; LY 29002; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EMBRYO; BACTERIAL INFECTION; BEHAVIOR DISORDER; BIOLOGY; CONGENITAL MALFORMATION; DEVELOPMENTAL STAGE; DISEASE MODEL; ENDOCRINE DISEASE; GENERAL ASPECTS OF DISEASE; HEMOSIDEROSIS; INFLAMMATORY DISEASE; LARVA; LEUKEMIA; MELANOMA; MENTAL DISEASE; METABOLIC DISORDER; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC ANIMAL; TUMOR; WOUND HEALING; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENETIC DISEASES, INBORN; HUMANS; MODELS, BIOLOGICAL; ZEBRAFISH;

ANIMALIA; DANIO RERIO; MURINAE; VERTEBRATA;

EID: 34247186766     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2091     Document Type: Review

References (125)

1. Nolan, P. M. et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature Genet. 25, 440-443 (2000).
2. Hrabe de Angelis, M.H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nature Genet. 25, 444-447 (2000).
3. Michaud, E. J. et al. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice. BMC Genomics 6, 164 (2005).
4. -/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl Acad. Sci. USA 101, 6553-6558 (2004).
5. Coghill, E. L. et al. A gene-driven approach to the identification of ENU mutants in the mouse. Nature Genet. 30, 255-256 (2002).
6. Quwailid, M. M. et al. A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome 15, 585-591 (2004).
7. Roosen-Runge, E. Observations of the early development of the zebrafish. Brachydanio rerio. Anat. Rec. 70, S103 (1937).
8. Laale, H. W. The biology and use of zebrafish, Brachydanio rerio in fisheries research. A literature review. J. Fish. Biol. 10, 121-174 (1977).
9. Streisinger, G., Walker, C., Dower, N., Knauber, D. & Singer, F. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 291, 293-296 (1981).
10. Chakrabarti, S., Streisinger, G., Singer, F. & Walker, C. Frequency of γ-ray induced specific locus and recessive lethal mutations in mature germ cells of the zebrafish, Brachydanio rerio. Genetics 103, 109-123 (1983).
11. Walker, C. & Streisinger, G. Induction of mutations by γ-rays in pregonial germ cells of zebrafish embryos. Genetics 103, 125-136 (1983).
12. Grunwald, D. J. & Streisinger, G. Induction of recessive lethal and specific locus mutations in the zebrafish with ethyl nitrosourea. Genet. Res. 59, 103-116 (1992).
13. Solnica-Krezel, L., Schier, A. F. & Driever, W. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 136, 1401-1420 (1994).
14. Stuart, G. W., McMurray, J. V. & Westerfield, M. Replication, integration and stable germ-line transmission of foreign sequences injected into early zebrafish embryos. Development 103, 403-412 (1988).
15. Streisinger, G., Singer, F., Walker, C., Knauber, D. & Dower, N. Segregation analyses and gene-centromere distances in zebrafish. Genetics 112, 311-319 (1986).
16. Driever, W. et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123, 37-46 (1996).
17. Haffter, P. et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36 (1996). References 16 and 17 are back-to-back publications of the first two large ENU mutagenesis forwardgenetic screens in zebrafish, resulting in over a thousand mutants with specific developmental phenotypes.
18. Amsterdam, A. et al. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 13, 2713-2724 (1999). Describes the first large-scale insertional mutagenesis screen in zebrafish.
19. Amsterdam, A. & Hopkins, N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet. 22, 473-478 (2006).
20. Udvadia, A. J. & Linney, E. Windows into development: historic, current, and future perspectives on transgenic zebrafish. Dev. Biol. 256, 1-17 (2003).
21. Wienholds, E., Schulte-Merker, S., Walderich, B. & Plasterk, R. H. Target-selected inactivation of the zebrafish rag1 gene. Science 297, 99-102 (2002). The first report of TILLING for a zebrafish mutant allele.
22. Russell, W. L. et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl Acad. Sci. USA 76, 5818-5819 (1979).
23. Amsterdam, A. et al. Identification of 315 genes essential for early zebrafish development. Proc. Natl Acad. Sci. USA 101, 12792-12797 (2004).
24. Bassett, D. I. et al. Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development 130, 5851-5860 (2003).
25. Wang, H., Long, Q., Marty, S. D., Sassa, S. & Lin, S. A zebrafish model for hepatoerythropoietic porphyria. Nature Genet. 20, 239-243 (1998).
26. Childs, S. et al. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr. Biol. 10, 1001-1004 (2000).
27. Piotrowski, T. et al. The zebrafish van gogh mutation disrupts tbx1, which is involved in the DiGeorge deletion syndrome in humans. Development 130, 5043-5052 (2003).
28. Paw, B. H. et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nature Genet. 34, 59-64 (2003).
29. Sun, Z. et al. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131, 4085-4093 (2004).
30. Bahadori, R. et al. The zebrafish fade out mutant: a novel genetic model for Hermansky-Pudlak syndrome. Invest. Ophthalmol. Vis. Sci. 47, 4523-4531 (2006).
31. Siu, B. L. et al. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation 99, 1022-1026 (1999).
32. Xu, X. et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nature Genet. 30, 205-209 (2002).
33. Gerull, B. et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genet. 30, 201-204 (2002).
34. Haramis, A. P. et al. Adenomatous polyposis colideficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep. 7, 444-449 (2006).
35. Kato, S. et al. A computer image processing system for quantification of zebrafish behavior. J. Neurosci. Methods 134, 1-7 (2004).
36. Levin, E. D., Bencan, Z. & Cerutti, D. T. Anxiolytic effects of nicotine in zebrafish. Physiol. Behav. 54-58 (2006).
37. Levin, E. D. & Chen, E. Nicotinic involvement in memory function in zebrafish. Neurotoxicol. Teratol. 26, 731-735 (2004).
38. Levin, E. D., Chrysanthis, E., Yacisin, K. & Linney, E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol. Teratol. 25, 51-57 (2003).
39. Darland, T. & Dowling, J. E. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc. Natl Acad. Sci. USA 98, 11691-11696 (2001).
40. Yu, L., Tucci, V., Kishi, S. & Zhdanova, I. V. Cognitive aging in zebrafish. PLoS ONE 1, e14 (2006).
41. Lockwood, B., Bjerke, S., Kobayashi, K. & Guo, S. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol. Biochem. Behav. 77, 647-654 (2004).
42. McCallum, C. M., Comai, L., Greene, E. A. & Henikoff, S. Targeted screening for induced mutations. Nature Biotechnol. 18, 455-457 (2000).
43. Wienholds, E. et al. Efficient target-selected mutagenesis in zebrafish. Genome Res. 13, 2700-2707 (2003).
44. Sood, R. et al. Methods for reverse genetic screening in zebrafish by resequencing and TILLING. Methods 39, 220-227 (2006).
45. Berghmans, S. et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl Acad. Sci. USA 102, 407-412 (2005).
46. Hurlstone, A. F. et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425, 633-637 (2003).
47. Hammerschmidt, M., Blader, P. & Strahle, U. Strategies to perturb zebrafish development. Methods Cell Biol. 59, 87-115 (1999).
48. Nasevicius, A. & Ekker, S. C. Effective targeted gene 'knockdown' in zebrafish. Nature Genet. 26, 216-220 (2000). This paper demonstrated the utility of morpholino antisense oligonucleotides for transient knockdown of gene expression in zebrafish.
49. Ando, H., Furuta, T., Tsien, R. Y. & Okamoto, H. Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos. Nature Genet. 28, 317-325 (2001).
50. Winkler, C. et al. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev. 19, 2320-2330 (2005).
51. Brownlie, A. et al. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nature Genet. 20, 244-250 (1998).
52. Fan, L. & Collodi, P. Zebrafish embryonic stem cells. Methods Enzymol. 418, 64-677 (2006).
53. Langenau, D. M. et al. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 102, 6068-6073 (2005).
54. Kawakami, K. Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. Methods Cell Biol. 77, 201-222 (2004).
55. Balciunas, D. et al. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet. 2, e169 (2006).
56. Beckwith, L. G., Moore, J. L., Tsao-Wu, G. S., Harshbarger, J. C. & Cheng, K. C. Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Lab. Invest. 80, 379-385 (2000).
57. Spitsbergen, J. M. et al. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-Nnitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol. 28, 716-725 (2000).
58. Mizgireuv, I. V. & Revskoy, S. Y. Transplantable tumor lines generated in clonal zebrafish. Cancer Res. 66, 3120-3125 (2006).
59. Moore, J. L., Rush, L. M., Breneman, C., Mohideen, M. A. & Cheng, K. C. Zebrafish genomic instability mutants and cancer susceptibility. Genetics 174, 585-600 (2006).
60. Shepard, J. L. et al. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev. 21, 55-59 (2007).
61. Shepard, J. L. et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc. Natl Acad. Sci. USA 102, 13194-13199 (2005).
62. Spitsbergen, J. M. & Kent, M. L. The state of the art of the zebrafish model for toxicology and toxicologic pathology research - advantages and current limitations. Toxicol. Pathol. 31, S62-S87 (2003).
63. Langenau, D. M. et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 299, 887-890 (2003).
64. Langenau, D. M. et al. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 105, 3278-3285 (2005).
65. Sabaawy, H. E. et al. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 103, 15166-15171 (2006).
66. Chen, J. et al. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 21, 462-471 (2007).
67. Patton, E. E. et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15, 249-254 (2005).
68. Topczewska, J. M. et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Med. 12, 925-932 (2006).
69. Haldi, M., Ton, C., Seng, W. L. & McGrath, P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9, 139-151 (2006).
70. Lamason, R. L. et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 310, 1782-1786 (2005).
71. Tsai, T., Vu, C. & Henson, D. E. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res. 15, 213-217 (2005).
72. Lawson, N. D. & Weinstein, B. M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307-318 (2002).
73. Huang, C. C., Lawson, N. D., Weinstein, B. M. & Johnson, S. L. reg6 is required for branching morphogenesis during blood vessel regeneration in zebrafish caudal fins. Dev. Biol. 264, 263-274 (2003).
74. Kuchler, A. M. et al. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr. Biol. 16, 1244-1248 (2006).
75. Yaniv, K. et al. Live imaging of lymphatic development in the zebrafish. Nature Med. 12, 711-716 (2006).
76. Stern, H. M. & Zon, L. I. Cancer genetics and drug discovery in the zebrafish. Nature Rev. Cancer 3, 533-539 (2003).
77. Stern, H. M. et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nature Chem. Biol. 1, 366-370 (2005).
78. Nelms, K. A. & Goodnow, C. C. Genome-wide ENU mutagenesis to reveal immune regulators. Immunity 15, 409-418 (2001).
79. Kasahara, M., Suzuki, T. & Pasquier, L. D. On the origins of the adaptive immune system: novel insights from invertebrates and cold-blooded vertebrates. Trends Immunol. 25, 105-111 (2004).
80. van der Sar, A. M., Appelmelk, B. J., Vandenbroucke-Grauls, C. M. & Bitter, W. A star with stripes: zebrafish as an infection model. Trends Microbiol. 12, 451-457 (2004).
81. Meijer, A. H. et al. Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection. Mol. Immunol. 42, 1185-1203 (2005).
82. Herbomel, P., Thisse, B. & Thisse, C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 126, 3735-3745 (1999).
83. Lieschke, G. J., Oates, A. C., Crowhurst, M. O., Ward, A. C. & Layton, J. E. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 98, 3087-3096 (2001).
84. Bennett, C. M. et al. Myelopoiesis in the zebrafish, Danio rerio. Blood 98, 643-651 (2001).
85. Altmann, S. M., Mellon, M. T., Distel, D. L. & Kim, C. H. Molecular and functional analysis of an interferon gene from the zebrafish, Danio rerio. J. Virol. 77, 1992-2002 (2003).
86. Oates, A. C. et al. Zebrafish stat3 is expressed in restricted tissues during embryogenesis and stat1 rescues cytokine signaling in a STAT1-deficient human cell line. Dev. Dyn. 215, 352-370 (1999).
87. Schorpp, M. et al. Conserved functions of Ikaros in vertebrate lymphocyte development: genetic evidence for distinct larval and adult phases of T cell development and two lineages of B cells in zebrafish. J. Immunol. 177, 2463-2476 (2006).
88. Traver, D. et al. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nature Immunol. 4, 1238-1246 (2003).
89. Ward, A. C. et al. The zebrafish spi1 promoter drives myeloid-specific expression in stable transgenic fish. Blood 102, 3238-3240 (2003).
90. Redd, M. J., Kelly, G., Dunn, G., Way, M. & Martin, P. Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil. Cytoskeleton 63, 415-422 (2006).
91. Renshaw, S. A. et al. A transgenic zebrafish model of neutrophilic inflammation. Blood 108, 3976-3978 (2006).
92. Mathias, J. R. et al. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. (2006). References 90-92 demonstrate the use of transgenic zebrafish with fluorescent leukocytes to study cellular processes in acute inflammation in vivo.
93. Davis, J. M. et al. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693-702 (2002).
94. van der Sar, A. M. et al. Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol. 5, 601-611 (2003).
95. Watral, V. & Kent, M. L. Pathogenesis of Mycobacterium spp. in zebrafish (Danio rerio) from research facilities. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 145, 55-60 (2006).
96. Swaim, L. E. et al. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect. Immun. 74, 6108-6117 (2006).
97. Peterson, R. T., Link, B. A., Dowling, J. E. & Schreiber, S. L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl Acad. Sci. USA 97, 12965-12969 (2000). The first demonstration of the feasibility of using zebrafish embryos for chemical library bioactivity screening.
98. Burns, C. G. et al. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nature Chem. Biol. 1, 263-264 (2005). The first description of a whole-animal based high-throughput screening tool for a dynamic physiological function using fluorescent zebrafish.
99. Margolis, J. & Plowman, G. D. Overcoming the gridlock in discovery research. Nature Biotechnol. 22, 522-524 (2004).
100. Peterson, R. T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nature Biotechnol. 22, 595-599 (2004).
101. Hong, C. C., Peterson, Q. P., Hong, J. Y. & Peterson, R. T. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr. Biol. 16, 1366-1372 (2006).
102. Weinstein, B. M., Stemple, D. L., Driever, W. & Fishman, M. C. gridlock, a localized heritable vascular patterning defect in the zebrafish. Nature Med. 1, 1143-1147 (1995).
103. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. & Fishman, M. C. gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824 (2000).
104. Zhong, T. P., Childs, S., Leu, J. P. & Fishman, M. C. Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220 (2001).
105. Murphey, R. D., Stern, H. M., Straub, C. T. & Zon, L. I. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem. Biol. Drug Des. 68, 213-219 (2006).
106. Imamura, S. & Kishi, S. Molecular cloning and functional characterization of zebrafish ATM. Int. J. Biochem. Cell Biol. 37, 1105-1116 (2005).
107. Amsterdam, A. et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2, e139 (2004). A new hypothesis about a mechanism of carcinogenesis arising out of the broad unbiased genomic overview of a large-scale insertional mutagenesis screen.
108. Bayliss, P. E. et al. Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nature Chem. Biol. 2, 265-273 (2006).
109. Rawls, J. F. & Johnson, S. L. Zebrafish kit mutation reveals primary and secondary regulation of melanocyte development during fin stripe regeneration. Development 127, 3715-3724 (2000).
110. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 (2002).
111. Lepilina, A. et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127, 607-619 (2006).
112. Traver, D. et al. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 104, 1298-1305 (2004).
113. Langenau, D. M. et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc. Natl Acad. Sci. USA 101, 7369-7374 (2004).
114. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
115. Fleming, R. E. & Sly, W. S. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J. Clin. Invest. 108, 521-522 (2001).
116. van der Ven, L. T., van den Brandhof, E. J., Vos, J. H., Power, D. M. & Wester, P. W. Effects of the antithyroid agent propylthiouracil in a partial life cycle assay with zebrafish. Environ. Sci. Technol. 40, 74-81 (2006).
117. Elsalini, O. A. & Rohr, K. B. Phenylthiourea disrupts thyroid function in developing zebrafish. Dev. Genes Evol. 212, 593-598 (2003).
118. Lam, S. H., Sin, Y. M., Gong, Z. & Lam, T. J. Effects of thyroid hormone on the development of immune system in zebrafish. Gen. Comp. Endocrinol. 142, 325-335 (2005).
119. Biga, P. R. & Goetz, F. W. Zebrafish and giant danio as models for muscle growth: determinate vs. indeterminate growth as determined by morphometric analysis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1327-R1337 (2006).
120. Goldsmith, M. I., Iovine, M. K., O'Reilly-Pol, T. & Johnson, S. L. A developmental transition in growth control during zebrafish caudal fin development. Dev. Biol. 296, 450-457 (2006).
121. Jagadeeswaran, P. & Sheehan, J. P. Analysis of blood coagulation in the zebrafish. Blood Cells Mol. Dis. 25, 239-249 (1999).
122. Spence, R., Jordan, W. C. & Smith, C. Genetic analysis of male reproductive success in relation to density in the zebrafish, Danio rerio. Front. Zool. 3, 5 (2006).
123. Amanuma, K., Takeda, H., Amanuma, H. & Aoki, Y. Transgenic zebrafish for detecting mutations caused by compounds in aquatic environments. Nature Biotechnol. 18, 62-65 (2000).
124. Yabu, T. et al. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 106, 125-134 (2005).
125. Liu, F. J., Wang, J. S. & Theodorakis, C. W. Thyrotoxicity of sodium arsenate, sodium perchlorate, and their mixture in zebrafish Danio rerio. Environ. Sci. Technol. 40, 3429-3436 (2006).